Cargando…
Dysosmia and dysgeusia associated with duloxetine
Common adverse effects of serotonin–norepinephrine reuptake inhibitors are nausea, dry mouth, dizziness and headache. We describe the case of a patient with dysosmia and subsequent dysgeusia associated with duloxetine. A 68-year-old Japanese woman with a history of type 1 diabetes mellitus, hyperten...
Autores principales: | Yoshida, Katsuyuki, Fukuchi, Takahiko, Sugawara, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720271/ https://www.ncbi.nlm.nih.gov/pubmed/29170185 http://dx.doi.org/10.1136/bcr-2017-222470 |
Ejemplares similares
-
Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan
por: Sheng, Wang-Huei, et al.
Publicado: (2021) -
Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation
por: Keyhan, Seied Omid, et al.
Publicado: (2020) -
Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review
por: Spencer, Ana Sofia, et al.
Publicado: (2021) -
Therapeutic support protocol for patient with dysosmia with or without dysgeusia related to the SARS-CoV2 virus infection
por: Milone, Ignazio, et al.
Publicado: (2020) -
Native mitral valve infective endocarditis caused by Staphylococcus warneri: A case‐based review
por: Kurihara, Ibuki, et al.
Publicado: (2021)